The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review
Abstract
Oxidative stress, manifested by protein oxidation, lipid peroxidation, DNA oxidation and 3-nitrotyrosine formation, among other indices, is observed in Alzheimer's disease (AD) brain. Amyloid beta-peptide (1-42) [Abeta(1-42)] may be central to the pathogenesis of AD. Our laboratory and others have implicated Abeta(1-42)-induced free radical oxidative stress in the neurodegeneration observed in AD brain. This paper reviews some of these studies from our laboratory. Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Abeta(1-42) was critical to its oxidative stress and neurotoxic properties. Because the C-terminal region of Abeta(1-42) is helical, and invoking the i + 4 rule of helices, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter. This interaction could alter the susceptibility for oxidation of Met-35, i.e. free radical formation. Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Abeta(1-42). Removal of the Met-35 residue from the lipid bilayer by substitution of the negatively charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Abeta(1-42). The free radical scavenger vitamin E prevented A(beta (1-42)-induced ROS formation, protein oxidation, lipid peroxidation, and neurotoxicity in hippocampal neurons, consistent with our model for Abeta-associated free radical oxidative stress induced neurodegeneration in AD. ApoE, allele 4, is a risk factor for AD. Synaptosomes from apoE knock-out mice are more vulnerable to Abeta-induced oxidative stress (protein oxidation, lipid peroxidation, and ROS generation) than are those from wild-type mice. We also studied synaptosomes from allele-specific human apoE knock-in mice. Brain membranes from human apoE4 mice have greater vulnerability to Abeta(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indices, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder. Using immunoprecipitation of proteins from AD and control brain obtained no longer than 4h PMI, selective oxidized proteins were identified in the AD brain. Creatine kinase (CK) and beta-actin have increased carbonyl groups, an index of protein oxidation, and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidation product, 4-hydroxy-2-nonenal (HNE). Abeta inhibits CK and causes lipid peroxidation, leading to HNE formation. Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD. Other oxidatively modified proteins have been identified in AD brain by proteomics analysis, and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degradation of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy production (alpha-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2). Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Abeta(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Abeta(1-42)-induced oxidative stress and neurodegeneration in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and mitochondrial dysfunction are prominent features of many neurodegenerative diseases including AD (Butterfield, 2002; Butterfield and Boyd-Kimball, 2018; Sharma and Kim, 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
In the citing paper
“For the same reason, the Aβ insertion into the lipid bilayer of the neuronal plasma membrane induces lipid peroxidation in a direct manner (Butterfield, 2002).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781
Cited by
Sorted by citations
Items 101–200 of 794
Dorr, A. E., Sahota, B., Chinta, L. V., Brown, M. E., Lai, A. Y., Ma, K., Hawkes, C. A., McLaurin, J., & Stefanovic, B. (2012) · Brain · doi:10.1093/brain/aws243 · Cited by 156
Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model
Kim, H. V., Kim, H. Y., Ehrlich, H. Y., Choi, S. Y., Kim, D. J., & Kim, Y. S. (2012) · Amyloid · doi:10.3109/13506129.2012.751367 · Cited by 152
Picone, P., Bondì, M. L., Picone, P., Bondì, M. L., Montana, G., Bruno, A., Pitarresi, G. L., Giammona, G., & Carlo, M. D. (2009) · Free Radical Research · doi:10.1080/10715760903214454 · Cited by 156
Mitoenergetic failure in Alzheimer disease
Parihar, M. S., & Brewer, G. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00232.2006 · Cited by 153
Telomerase, mitochondria and oxidative stress
Saretzki, G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.05.004 · Cited by 128
Ikram, M. A., Park, T. J., Ali, T., & Kim, M. O. (2020) · Antioxidants · doi:10.3390/antiox9090902 · Cited by 151
Durairajan, S. S. K., Yuan, Q., Xie, L., Chan, W. S., Kum, W.-F., Koo, I., Liu, C., Song, Y., Huang, J., Klein, W. L., et al. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.09.006 · Cited by 149
Wáng, Y., Zhang, M., Li, Z., Yue, J., Xu, M., Zhang, Y., Yung, K. K. L., & Li, R. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.11.149 · Cited by 149
Tripathi, P. N., Lodhi, A., Rai, S., Nandi, N., Dumoga, S., Yadav, P., Tiwari, A., Singh, S. K., El‐Shorbagi, A., & Chaudhary, S. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s452009 · Cited by 151
Chronic Intermittent Fasting Improves Cognitive Functions and Brain Structures in Mice
Li, L., Wang, Z., & Zuo, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066069 · Cited by 147
“Since oxidative stress is a known factor contributing to brain aging [15] and can induce cell injury and impairment of learning and memory [12,13], our results indicate that reduced oxidative stress may be a mechanism for the improved brain functions and structures in the intermittent fasting mice.”
BackgroundCarbon nanotubes: promising agents against free radicals
Galano, A. (2010) · Nanoscale · doi:10.1039/b9nr00364a · Cited by 148
Global Analysis of Protein Damage by the Lipid Electrophile 4-Hydroxy-2-nonenal
Codreanu, S. G., Zhang, B., Sobecki, S. M., Billheimer, D. D., & Liebler, D. C. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800070-mcp200 · Cited by 147
Wang, Z., Guo, W., Kuang, X., Hou, S., & Liu, H. (2017) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.05.006 · Cited by 150
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases
Calabrese, V. (2009) · Frontiers in bioscience · doi:10.2741/3250 · Cited by 145
Pomara, N., Bruno, D., Sarreal, A. S., Hernando, R. T., Nierenberg, J. J., Petkova, E., Sidtis, J. J., Wısnıewskı, T., Mehta, P. D., Praticò, D., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11081153 · Cited by 143
Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
Mutter, J., Naumann, J., Sadaghiani, C., Schneider, R., & Walach, H. (2004) · PubMed · Cited by 143
Debra Boyd-kimball, A., Castegna, A., Rukhsana Sultana, A., Poon, H. F., Petroze, R. T., Lynn, B. C., Klein, J. B., & Butterfield, D. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.086 · Cited by 141
DiMarco, T., & Giulivi, C. (2006) · Mass Spectrometry Reviews · doi:10.1002/mas.20109 · Cited by 141
Liu, J., & Ames, B. N. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047161 · Cited by 138
Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase
Atamna, H., & Kumar, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100414 · Cited by 142
Galano, A. (2017) · Journal of the Mexican Chemical Society · doi:10.29356/jmcs.v59i4.81 · Cited by 136
Metallothionein in Brain Disorders
Juárez-Rebollar, D., Rı́os, C., Nava-Ruíz, C., & Méndez‐Armenta, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5828056 · Cited by 134
NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models
COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129
Barros, M. P., Poppe, S. C., & Bondan, E. F. (2014) · Nutrients · doi:10.3390/nu6031293 · Cited by 134
Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease
Kontush, A., & Schekatolina, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.025 · Cited by 132
Barone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.018 · Cited by 127
General aspects of neurodegeneration
Jellinger, K. A. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-0643-3_7 · Cited by 126
Caruso, G., Fresta, C. G., Musso, N., Giambirtone, M., Grasso, M., Spampinato, S. F., Merlo, S., Drago, F., Lazzarino, G., Sortino, M. A., et al. (2019) · Cells · doi:10.3390/cells8010064 · Cited by 129
Uddin, M. S., Kabir, M. T., Rahman, M. S., Behl, T., Jeandet, P., Ashraf, G. M., Najda, A., Bin-Jumah, M. N., El-Seedi, H. R., & Abdel‐Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165858 · Cited by 131
Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 126
Poon, H. F., Farr, S. A., Thongboonkerd, V., Lynn, B. C., Banks, W. A., Morley, J. E., Klein, J. B., & Butterfield, D. A. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.07.008 · Cited by 126
Sultana, R., Perluigi, M., Newman, S. F., Pierce, W. M., Cini, C., Coccia, R., & Butterfield, D. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2810 · Cited by 125
Perluigi, M., Joshi, G., Sultana, R., Calabrese, V., De Marco, C., Coccia, R., Cini, C., & Butterfield, D. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20879 · Cited by 125
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 123
RetractedCalabrese, V., Butterfield, D. A., Scapagnini, G., Stella, A. M. G., & Maines, M. D. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.444 · Cited by 122
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129033 · Cited by 134
Jayasena, T., Poljak, A., Smythe, G. A., Braidy, N., Münch, G. W., & Sachdev, P. S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.003 · Cited by 122
Gururaj Joshi, A., Marzia Perluigi, A., Rukhsana Sultana, A., Ravagna, A., Calabrese, V., & Butterfield, D. A. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.11.006 · Cited by 120
Feng, Y., Sun, C., Yuan, Y., Zhu, Y., Wan, J., Firempong, C. K., Omari‐Siaw, E., Xu, Y., Pu, Z., Yu, J., et al. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.081 · Cited by 119
Phospholipases A2Mediate Amyloid-β Peptide-Induced Mitochondrial Dysfunction
Zhu, D., Lai, Y., Shelat, P. B., Hu, C., Sun, G. Y., & Lee, J. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3505-06.2006 · Cited by 119
Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
García‐Escudero, V., Martín-Maestro, P., Perry, G. L., & Ávila, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/162152 · Cited by 120
Shen, L., & Ji, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150140 · Cited by 118
Calabrese, V., Stella, A. M. G., Butterfield, D. A., & Scapagnini, G. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2004.6.895 · Cited by 117
Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin
Rigacci, S., Guidotti, V., Bucciantini, M., Parri, M., Nediani, C., Cerbai, E., Stefani, M., & Berti, A. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.010 · Cited by 118
Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., & Sugimoto, H. (2008) · Neuroreport · doi:10.1097/wnr.0b013e32830b8ae1 · Cited by 115
Antioxidant Properties and Neuroprotective Capacity of Strawberry Tree Fruit (Arbutus unedo)
Fortalezas, S., Tavares, L., Pimpão, R. C., Tyagi, M., Pontes, V., Alves, P. M., McDougall, G. J., Stewart, D., Ferreira, R. B., & dos Santos, C. N. (2010) · Nutrients · doi:10.3390/nu2020214 · Cited by 115
Capsaicin, a Tasty Free Radical Scavenger: Mechanism of Action and Kinetics
Galano, A., & Martı́nez, A. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp211172f · Cited by 115
Salvia miltiorrhiza: A source for anti-Alzheimer’s disease drugs
Zhang, X., Qian, S., Zhang, Y.-J., & Wang, R. L. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1027408 · Cited by 114
Acrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease
Pocernich, C. B., & Butterfield, D. A. (2003) · Neurotoxicity Research · doi:10.1007/bf03033161 · Cited by 111
The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities
Rohn, T. T. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0463-2 · Cited by 112
Shidore, M. M., Machhi, J., Shingala, K., Murumkar, P. R., Sharma, M. K., Agrawal, N., Tripathi, A., Parikh, Z. S., Pillai, P. P., & Yadav, M. R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00426 · Cited by 114
The impact of oxidative stress on chaperone-mediated human sperm–egg interaction
Bromfield, E. G., Aitken, R. J., Anderson, A. L., McLaughlin, E. A., & Nixon, B. (2015) · Human Reproduction · doi:10.1093/humrep/dev214 · Cited by 111
Alzheimer’ s disease, oxidative stress and gammahydroxybutyrate
Mamelak, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.008 · Cited by 108
Yarian, C. S., Rebrin, I., & Sohal, R. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.135 · Cited by 111
Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease
Kabir, M. T., Uddin, M. S., Zaman, S., Begum, Y., Ashraf, G. M., Bin-Jumah, M. N., BUNGAU, S. G., Mousa, S. A., & Abdel‐Daim, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02096-w · Cited by 113
Sadowski, M., Pankiewicz, J. E., Scholtzova, H., Ji, Y., Quartermain, D., Jensen, C. H., Duff, K., Nixon, R. A., Gruen, R. J., & Wısnıewskı, T. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.418 · Cited by 108
The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease
Grimm, M. O. W., Mett, J., & Hartmann, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111785 · Cited by 112
Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins
Murray, I. V. J., Sindoni, M. E., & Axelsen, P. H. (2005) · Biochemistry · doi:10.1021/bi050926p · Cited by 107
Melatonin Redox Activity. Its Potential Clinical Applications in Neurodegenerative Disorders
Miller, E. D., Morel, A., Saso, L., & Saluk, J. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666141209160556 · Cited by 105
Genetics, Transcriptomics, and Proteomics of Alzheimers Disease
Papassotiropoulos, A., Fountoulakis, M., Dunckley, T. L., Stephan, D. A., & Reiman, E. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0418 · Cited by 105
Muffat, J., Walker, D. W., & Benzer, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800896105 · Cited by 112
Banks, W. A., Farr, S. A., Morley, J. E., Wolf, K. M., Geylis, V., & Steinitz, M. O. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.005 · Cited by 103
Brain Endothelial Cells Synthesize Neurotoxic Thrombin in Alzheimer’s Disease
Yin, X., Wright, J., Wall, T., & Grammas, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090406 · Cited by 104
Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants
Domenico, F. D., Barone, E., Marzia Perluigi, A., & Butterfield, D. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 103
Liang, J., Liu, L., & Xing, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.003 · Cited by 102
Slow Excitotoxicity in Alzheimer's Disease
Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121990 · Cited by 106
The use of mouse models to understand and improve cognitive deficits in Down syndrome
Das, I., & Reeves, R. H. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007716 · Cited by 103
Boyd-Kimball, D., Poon, H. F., Lynn, B. C., Cai, J., Pierce Jr., W. M., Klein, J. B., Ferguson, J., Link, C. D., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.001 · Cited by 98
Erickson, M. A., Hansen, K. M., & Banks, W. A. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.07.003 · Cited by 102
The Environment, Epigenetics and Amyloidogenesis
Wu, J., Basha, R. M., & Zawia, N. H. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0009-4 · Cited by 96
Businaro, R., Leone, S., Fabrizi, C., Sorci, G., Donato, R., Lauro, G. M., & Fumagalli, L. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20785 · Cited by 98
Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress
Tripathy, D., & Grammas, P. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-10 · Cited by 97
Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease
Bishop, G. M., & Robinson, S. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421100-00001 · Cited by 94
Quiroz‐Baez, R., Rojas, E., & Arias, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.06.012 · Cited by 93
Rukhsana Sultana, A., Newman, S. F., Abdul, H. M., Keller, J. N., & Butterfield, D. A. (2004) · Free Radical Research · doi:10.1080/1071576042000206478 · Cited by 91
Treatment of Alzheimer’s Disease with a Cholinesterase Inhibitor Combined with Antioxidants
Cornelli, U. (2010) · Neurodegenerative Diseases · doi:10.1159/000295663 · Cited by 90
Mitochondrial SIRT3 and neurodegenerative brain disorders
Anamika, A., Khanna, A., Acharjee, P., Acharjee, A., & Trigun, S. K. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.11.009 · Cited by 91
Luo, Y., Li, X., Zhao, Y., Du, Z., & Li, J. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.02.142 · Cited by 89
Khezri, M. R., Yousefi, K., Esmaeili, A., & Ghasemnejad‐Berenji, M. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01191-x · Cited by 93
Ong, W.-Y., & Halliwell, B. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.005 · Cited by 89
Melatonin Relieves the Neural Oxidative Burden that Contributes to Dementias
Reiter, R. J., Tan, D. X., & Pappolla, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.012 · Cited by 89
Age-Related Macular Degeneration and Retinal Protein Modification by 4-Hydroxy-2-nonenal
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1058 · Cited by 93
Amyloid β Levels in Human Red Blood Cells
Kiko, T., Nakagawa, K., Satoh, A., Tsuduki, T., Furukawa, K., Arai, H., & Miyazawa, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049620 · Cited by 92
Actin Cys374 as a nucleophilic target of α,β-unsaturated aldehydes
Dalle‐Donne, I., Carini, M., Vistoli, G., Gamberoni, L., Giustarini, D., Colombo, R., Facino, R. M., Rossi, R., Milzani, A., & Aldini, G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.026 · Cited by 88
PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage
Martire, S., Fuso, A., Rotili, D., Tempera, I., Giordano, C., Zottis, I. D., Muzi, A., Vernole, P., Graziani, G., Lococo, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072169 · Cited by 85
León‐Carmona, J. R., Alvarez-Idaboy, J. R., & Galano, A. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp40651a · Cited by 86
Free Radicals, Antioxidants and Disease
Sharma, N. (2014) · Biology and Medicine · doi:10.4172/0974-8369.1000214 · Cited by 91
Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?
Waldmeier, P. C., & Tatton, W. G. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)03000-9 · Cited by 85
Pogocki, D., Ruman, T., Danilczuk, M., Danilczuk, M., Celuch, M., & Wałajtys-Rode, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.038 · Cited by 84
Oeltzschner, G., Wijtenburg, S. A., Mikkelsen, M. E., Edden, R. A. E., Barker, P. B., Joo, J. H., Leoutsakos, J., Rowland, L. M., Workman, C. I., & Smith, G. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.027 · Cited by 87
P2Y2 Nucleotide Receptor-Mediated Responses in Brain Cells
Peterson, T. S., Camden, J. M., Wang, Y., Seye, C. I., Wood, W. G., Sun, G. Y., Erb, L., Petris, M. J., & Weisman, G. A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8115-7 · Cited by 89
Abdel‐Salam, O. M. E., Salem, N. A., & Hussein, J. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9264-9 · Cited by 83
Aquaporin-4 mediates astrocyte response to β-amyloid
Yang, W., Wu, Q., Chan, Y., Gao, J., Xiao, M., Gu, M., Ding, J., & Hu, G. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.02.002 · Cited by 84
Neuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.117 · Cited by 83
Iraji, A., Firuzi, O., Khoshneviszadeh, M., Tavakkoli, M., Mahdavi, M. R., Nadri, H., Edraki, N., & Miri, R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.057 · Cited by 83
Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Błasiak, J., Sobczuk, P., Pawłowska, E., & Kaarniranta, K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101735 · Cited by 86
Boyd-Kimball, D., Sultana, R., Abdul, H. M., & Butterfield, D. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6509 · Cited by 83
Choi, H., Park, H., Koh, S., Choi, N.-Y., Yu, H., Park, J., Lee, Y. J., & Lee, K. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.005 · Cited by 82
Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents
Li, X., Wang, H., Lu, Z., Zheng, X., Wei Min, N. I., Zhu, J., Fu, Y., Lian, F., Zhang, N., Li, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00636 · Cited by 83
The protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 84
Metadata
- Authors
- Allan Butterfield, D.
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 36
- Issue
- 12
- Pages
- 1307-1313
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W2153767421
- Cited by
- 786
- References
- 58
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 18 · 2023: 21 · 2022: 24 · 2021: 34 · 2020: 26 · 2019: 28 · 2018: 30 · 2017: 32 · 2016: 45 · 2015: 43 · 2014: 42 · 2013: 39 · 2012: 42
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institute on Aging (P01AG010836, P01AG005119, AG 10836, AG12423, AG0 5119, R01AG012423)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid beta peptide 1-42, oxidative stress, neurotoxicity, Alzheimer's disease, protein oxidation, lipid peroxidation, nitrotyrosine, vitamin E, hippocampal neurons, synaptosomes, apolipoprotein E, APOE ε4, amyloid fibril formation, neurodegeneration, lipid bilayers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Humans, Lipid Bilayers, Methionine, Molecular Sequence Data, Neurons, Peptide Fragments, Peptides, Free Radical Scavengers, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Structure, Tertiary, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review